City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
230687
Name:
Settlement of Lawsuit - Teva Pharmaceuticals USA,
Inc. and Related Entities - City to Receive
$24,797,604 Over 13 Years
Status:
Type:
Ordinance
Passed
File created:
In control:
6/13/2023
Clerk of the Board
On agenda:
Final action:
6/13/2023
9/15/2023
Enactment date:
9/15/2023
191-23
Enactment #:
Title:
Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the
People of the State of California against Cephalon, Inc.; Teva Pharmaceuticals USA, Inc.; Teva
Pharmaceutical Industries Ltd; Watson Laboratories, Inc.; Actavis LLC; Actavis Pharma, Inc. (f/k/a
Watson Pharma, Inc.); Actavis Elizabeth LLC; Actavis Mid Atlantic LLC; Warner Chilcott Company,
LLC; Actavis South Atlantic LLC; Actavis Totowa LLC; Actavis Kadian LLC; Actavis Laboratories UT,
Inc. (f/k/a/ Watson Laboratories, Inc.-Salt Lake City); Actavis Laboratories FL, Inc. (f/k/a Watson
Laboratories, Inc.-Florida); and Anda, Inc. for $24,797,604 (the City to be paid $19,499,928 over 13
years, the City’s outside counsel to be paid $3,043,340, and the City Attorney’s Office to be paid
$2,254,336) and naloxone valued at $20,000,000; directing the Controller to allocate funds to the City
Attorney’s Office as provided in the settlement agreement; the lawsuit was filed on December 18,
2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-
CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v.
Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A.
Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the
Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc.,
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo
Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics,
Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc.
n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma,
Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit
involves allegations that the Teva defendants created a public nuisance and violated the Unfair
Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and
distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of
the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid
orders as required by state and federal law.
Sponsors:
Attachments:
1. Leg Ver1, 2. Comm Pkt 072023, 3. Board Pkt 090523, 4. Board Pkt 091223, 5. Leg Final
Action By
Date
Action
Result
Ver.
RECEIVED FROM DEPARTMENT
Clerk of the Board
5/26/2023
1
RECEIVED AND ASSIGNED
President
6/13/2023
1
RECOMMENDED
Government Audit and Oversight
Committee
7/20/2023
1
Pass
PASSED ON FIRST READING
Board of Supervisors
9/5/2023
1
Pass
FINALLY PASSED
Board of Supervisors
9/12/2023
1
Pass
APPROVED
Mayor
9/15/2023
1